BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Redondo-pachón D, Crespo M, Yélamos J, Muntasell A, Pérez-sáez MJ, Pérez-fernández S, Vila J, Vilches C, Pascual J, López-botet M. Adaptive NKG2C + NK Cell Response and the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients. J I 2016;198:94-101. [DOI: 10.4049/jimmunol.1601236] [Cited by in Crossref: 32] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Bergantini L, d'Alessandro M, Otranto A, Cavallaro D, Gangi S, Fossi A, Perillo F, Luzzi L, Zanfrini E, Paladini P, Sestini P, Rottoli P, Bargagli E, Bennett D. Characterization of NKG2-A/-C, Kir and CD57 on NK Cells Stimulated with pp65 and IE-1 Antigens in Patients Awaiting Lung Transplant. Life (Basel) 2022;12:1081. [PMID: 35888169 DOI: 10.3390/life12071081] [Reference Citation Analysis]
2 Aviles-padilla K, Angelo LS, Fan D, Paust S. CXCR6+ and NKG2C+ Natural Killer Cells Are Distinct With Unique Phenotypic and Functional Attributes Following Bone Marrow Transplantation. Front Immunol 2022;13:886835. [DOI: 10.3389/fimmu.2022.886835] [Reference Citation Analysis]
3 Gao F, Zhou Z, Lin Y, Shu G, Yin G, Zhang T. Biology and Clinical Relevance of HCMV-Associated Adaptive NK Cells. Front Immunol 2022;13:830396. [PMID: 35464486 DOI: 10.3389/fimmu.2022.830396] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Toson B, Michita RT, Matte MCT, Soares R, Lawisch GKS, Mattevi VS, Chies JAB. Assessment of NKG2C copy number variation in HIV-1 infection susceptibility, and considerations about the potential role of lacking receptors and virus infection. J Hum Genet 2022. [PMID: 35314764 DOI: 10.1038/s10038-022-01029-w] [Reference Citation Analysis]
5 Capuano C, Pighi C, Battella S, Pulcinelli F, Santoro C, Ferretti A, Turriziani O, De Federicis D, Fionda C, Sciumè G, Galandrini R, Palmieri G. (Auto)Antibody Responses Shape Memory NK Cell Pool Size and Composition. Biomedicines 2022;10:625. [DOI: 10.3390/biomedicines10030625] [Reference Citation Analysis]
6 Ishiyama K, Arakawa-Hoyt J, Aguilar OA, Damm I, Towfighi P, Sigdel T, Tamaki S, Babdor J, Spitzer MH, Reed EF, Sarwal MM, Lanier LL; CMV Systems Immunobiology Group. Mass cytometry reveals single-cell kinetics of cytotoxic lymphocyte evolution in CMV-infected renal transplant patients. Proc Natl Acad Sci U S A 2022;119:e2116588119. [PMID: 35181606 DOI: 10.1073/pnas.2116588119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Basílio-Queirós D, Venturini L, Luther-Wolf S, Dammann E, Ganser A, Stadler M, Falk CS, Weissinger EM. Adaptive NK cells undergo a dynamic modulation in response to human cytomegalovirus and recruit T cells in in vitro migration assays. Bone Marrow Transplant 2022. [PMID: 35177828 DOI: 10.1038/s41409-022-01603-y] [Reference Citation Analysis]
8 Ataya M, Redondo-Pachón D, Llinàs-Mallol L, Yélamos J, Alari-Pahissa E, Pérez-Sáez MJ, Altadill M, Raïch-Regué D, Vilches C, Pascual J, Crespo M, López-Botet M. Long-Term Evolution of the Adaptive NKG2C+ NK Cell Response to Cytomegalovirus Infection in Kidney Transplantation: An Insight on the Diversity of Host-Pathogen Interaction. J Immunol 2021;207:1882-90. [PMID: 34470855 DOI: 10.4049/jimmunol.2100055] [Reference Citation Analysis]
9 Vlahava VM, Murrell I, Zhuang L, Aicheler RJ, Lim E, Miners KL, Ladell K, Suárez NM, Price DA, Davison AJ, Wilkinson GW, Wills MR, Weekes MP, Wang EC, Stanton RJ. Monoclonal antibodies targeting nonstructural viral antigens can activate ADCC against human cytomegalovirus. J Clin Invest 2021;131:139296. [PMID: 33586678 DOI: 10.1172/JCI139296] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
10 Soleimanian S, Yaghobi R, Karimi MH, Geramizadeh B, Roozbeh J, Hossein Aghdaie M, Heidari M. Circulating NKG2C + NK cell expressing CD107a/LAMP-1 subsets at the onset of CMV reactivation in seropositive kidney transplant recipients. Transpl Immunol 2021;69:101460. [PMID: 34492297 DOI: 10.1016/j.trim.2021.101460] [Reference Citation Analysis]
11 Duygu B, Olieslagers TI, Groeneweg M, Voorter CEM, Wieten L. HLA Class I Molecules as Immune Checkpoints for NK Cell Alloreactivity and Anti-Viral Immunity in Kidney Transplantation. Front Immunol 2021;12:680480. [PMID: 34295330 DOI: 10.3389/fimmu.2021.680480] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Nelson CS, Baraniak I, Lilleri D, Reeves MB, Griffiths PD, Permar SR. Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease. J Infect Dis 2020;221:S45-59. [PMID: 32134477 DOI: 10.1093/infdis/jiz428] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
13 Hauser IA, Marx S, Sommerer C, Suwelack B, Dragun D, Witzke O, Lehner F, Schiedel C, Porstner M, Thaiss F, Neudörfl C, Falk CS, Nashan B, Sester M. Effect of everolimus-based drug regimens on CMV-specific T-cell functionality after renal transplantation: 12-month ATHENA subcohort-study results. Eur J Immunol 2021;51:943-55. [PMID: 33306229 DOI: 10.1002/eji.202048855] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
14 Sivori S, Pende D, Quatrini L, Pietra G, Della Chiesa M, Vacca P, Tumino N, Moretta F, Mingari MC, Locatelli F, Moretta L. NK cells and ILCs in tumor immunotherapy. Mol Aspects Med 2021;80:100870. [PMID: 32800530 DOI: 10.1016/j.mam.2020.100870] [Cited by in Crossref: 11] [Cited by in F6Publishing: 43] [Article Influence: 5.5] [Reference Citation Analysis]
15 Grutza R, Moskorz W, Senff T, Bäcker E, Lindemann M, Zimmermann A, Uhrberg M, Lang PA, Timm J, Cosmovici C. NKG2C pos NK Cells Regulate the Expansion of Cytomegalovirus-Specific CD8 T Cells. J I 2020;204:2910-7. [DOI: 10.4049/jimmunol.1901281] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
16 Nikolich-Žugich J, Čicin-Šain L, Collins-McMillen D, Jackson S, Oxenius A, Sinclair J, Snyder C, Wills M, Lemmermann N. Advances in cytomegalovirus (CMV) biology and its relationship to health, diseases, and aging. Geroscience 2020;42:495-504. [PMID: 32162210 DOI: 10.1007/s11357-020-00170-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
17 Pascual-Guardia S, Ataya M, Ramírez-Martínez I, Yélamos J, Chalela R, Bellido S, López-Botet M, Gea J. Adaptive NKG2C+ natural killer cells are related to exacerbations and nutritional abnormalities in COPD patients. Respir Res 2020;21:63. [PMID: 32131843 DOI: 10.1186/s12931-020-1323-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Kim KH, Yu HT, Hwang I, Park S, Park SH, Kim S, Shin EC. Phenotypic and Functional Analysis of Human NK Cell Subpopulations According to the Expression of FcεRIγ and NKG2C. Front Immunol 2019;10:2865. [PMID: 31867015 DOI: 10.3389/fimmu.2019.02865] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
19 Ataya M, Redondo‐pachón D, Llinàs‐mallol L, Yélamos J, Heredia G, Pérez‐sáez MJ, Vila J, Costa‐garcía M, Raïch‐regué D, Vilches C, Pascual J, Crespo M, López‐botet M. Pretransplant adaptive NKG2C+ NK cells protect against cytomegalovirus infection in kidney transplant recipients. Am J Transplant 2019;20:663-76. [DOI: 10.1111/ajt.15658] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
20 Moreira A, Alari-Pahissa E, Munteis E, Vera A, Zabalza A, Llop M, Villarrubia N, Costa-García M, Álvarez-Lafuente R, Villar LM, López-Botet M, Martínez-Rodríguez JE. Adaptive Features of Natural Killer Cells in Multiple Sclerosis. Front Immunol 2019;10:2403. [PMID: 31681293 DOI: 10.3389/fimmu.2019.02403] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
21 DeWolfe D, Aid M, McGann K, Ghofrani J, Geiger E, Helzer C, Malik S, Kleiboeker S, Jost S, Tan CS. NK Cells Contribute to the Immune Risk Profile in Kidney Transplant Candidates. Front Immunol 2019;10:1890. [PMID: 31507586 DOI: 10.3389/fimmu.2019.01890] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
22 Calabrese DR, Chong T, Wang A, Singer JP, Gottschall M, Hays SR, Golden JA, Kukreja J, Lanier LL, Tang Q, Greenland JR. NKG2C Natural Killer Cells in Bronchoalveolar Lavage Are Associated With Cytomegalovirus Viremia and Poor Outcomes in Lung Allograft Recipients. Transplantation 2019;103:493-501. [PMID: 30211828 DOI: 10.1097/TP.0000000000002450] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
23 Harpur CM, Stankovic S, Kanagarajah A, Widjaja JM, Levvey BJ, Cristiano Y, Snell GI, Brooks AG, Westall GP, Sullivan LC. Enrichment of Cytomegalovirus-induced NKG2C+ Natural Killer Cells in the Lung Allograft. Transplantation 2019;103:1689-99. [DOI: 10.1097/tp.0000000000002545] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
24 Dendle C, Polkinghorne KR, Mulley WR, Gan PY, Kanellis J, Stuart RL, Thursky K, Holdsworth SR. A simple score can identify kidney transplant recipients at high risk of severe infection over the following 2 years. Transpl Infect Dis 2019;21:e13076. [PMID: 30875147 DOI: 10.1111/tid.13076] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
25 Costa-García M, Ataya M, Moraru M, Vilches C, López-Botet M, Muntasell A. Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes. Front Immunol 2019;10:687. [PMID: 31001281 DOI: 10.3389/fimmu.2019.00687] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 4.7] [Reference Citation Analysis]
26 Dendle C, Mulley WR, Holdsworth S. Can immune biomarkers predict infections in solid organ transplant recipients? A review of current evidence. Transplant Rev (Orlando) 2019;33:87-98. [PMID: 30551846 DOI: 10.1016/j.trre.2018.10.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
27 Abel AM, Yang C, Thakar MS, Malarkannan S. Natural Killer Cells: Development, Maturation, and Clinical Utilization. Front Immunol 2018;9:1869. [PMID: 30150991 DOI: 10.3389/fimmu.2018.01869] [Cited by in Crossref: 229] [Cited by in F6Publishing: 359] [Article Influence: 57.3] [Reference Citation Analysis]
28 Cichocki F, Wu CY, Zhang B, Felices M, Tesi B, Tuininga K, Dougherty P, Taras E, Hinderlie P, Blazar BR, Bryceson YT, Miller JS. ARID5B regulates metabolic programming in human adaptive NK cells. J Exp Med 2018;215:2379-95. [PMID: 30061358 DOI: 10.1084/jem.20172168] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 13.5] [Reference Citation Analysis]
29 Dendle C, Gan PY, Polkinghorne KR, Ngui J, Stuart RL, Kanellis J, Thursky K, Mulley WR, Holdsworth S. Natural killer cell function predicts severe infection in kidney transplant recipients. Am J Transplant 2019;19:166-77. [PMID: 29708649 DOI: 10.1111/ajt.14900] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
30 Li M, Boddeda SR, Chen B, Zeng Q, Schoeb TR, Velazquez VM, Shimamura M. NK cell and Th17 responses are differentially induced in murine cytomegalovirus infected renal allografts and vary according to recipient virus dose and strain. Am J Transplant 2018;18:2647-62. [PMID: 29659179 DOI: 10.1111/ajt.14868] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
31 Terrén I, Mikelez I, Odriozola I, Gredilla A, González J, Orrantia A, Vitallé J, Zenarruzabeitia O, Borrego F. Implication of Interleukin-12/15/18 and Ruxolitinib in the Phenotype, Proliferation, and Polyfunctionality of Human Cytokine-Preactivated Natural Killer Cells. Front Immunol 2018;9:737. [PMID: 29713323 DOI: 10.3389/fimmu.2018.00737] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
32 Yu K, Davidson CL, Wójtowicz A, Lisboa L, Wang T, Airo AM, Villard J, Buratto J, Sandalova T, Achour A, Humar A, Boggian K, Cusini A, van Delden C, Egli A, Manuel O, Mueller N, Bochud PY, Burshtyn DN; Swiss Transplant Cohort Study. LILRB1 polymorphisms influence posttransplant HCMV susceptibility and ligand interactions. J Clin Invest 2018;128:1523-37. [PMID: 29528338 DOI: 10.1172/JCI96174] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
33 Litjens NHR, van der Wagen L, Kuball J, Kwekkeboom J. Potential Beneficial Effects of Cytomegalovirus Infection after Transplantation. Front Immunol 2018;9:389. [PMID: 29545802 DOI: 10.3389/fimmu.2018.00389] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 7.3] [Reference Citation Analysis]
34 Mian M, Natori Y, Ferreira V, Selzner N, Husain S, Singer L, Kim SJ, Humar A, Kumar D. Evaluation of a Novel Global Immunity Assay to Predict Infection in Organ Transplant Recipients. Clinical Infectious Diseases 2018;66:1392-7. [DOI: 10.1093/cid/cix1008] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
35 Vietzen H, Pollak K, Honsig C, Jaksch P, Puchhammer-stöckl E. NKG2C Deletion Is a Risk Factor for Human Cytomegalovirus Viremia and Disease After Lung Transplantation. The Journal of Infectious Diseases 2018;217:802-6. [DOI: 10.1093/infdis/jix608] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
36 Muntasell A, Cabo M, Servitja S, Tusquets I, Martínez-García M, Rovira A, Rojo F, Albanell J, López-Botet M. Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy. Front Immunol 2017;8:1544. [PMID: 29181007 DOI: 10.3389/fimmu.2017.01544] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]
37 Pupuleku A, Costa-García M, Farré D, Hengel H, Angulo A, Muntasell A, López-Botet M. Elusive Role of the CD94/NKG2C NK Cell Receptor in the Response to Cytomegalovirus: Novel Experimental Observations in a Reporter Cell System. Front Immunol 2017;8:1317. [PMID: 29114247 DOI: 10.3389/fimmu.2017.01317] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
38 Münz C, Chijioke O. Natural killer cells in herpesvirus infections. F1000Res 2017;6:F1000 Faculty Rev-1231. [PMID: 28781750 DOI: 10.12688/f1000research.11197.1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
39 López-Botet M, Vilches C, Redondo-Pachón D, Muntasell A, Pupuleku A, Yélamos J, Pascual J, Crespo M. Dual Role of Natural Killer Cells on Graft Rejection and Control of Cytomegalovirus Infection in Renal Transplantation. Front Immunol 2017;8:166. [PMID: 28261220 DOI: 10.3389/fimmu.2017.00166] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 5.4] [Reference Citation Analysis]